NCT01128842 2018-12-19
A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
Puma Biotechnology, Inc.
Phase 1 Completed
Clinical Trials
6 trialsNCT00768469 2018-11-19
Study Evaluating Safety And Tolerability, Solid Tumor
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00838539 2018-09-18
Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00146172 2018-09-17
Study Evaluating HKI-272 in Tumors
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00397046 2018-09-14
A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors
Puma Biotechnology, Inc.
Phase 1 Completed
NCT00958724 2018-06-28
Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors
Puma Biotechnology, Inc.
Phase 1 Completed